Measures of ventilation heterogeneity mapped with hyperpolarized helium‐3 MRI demonstrate a T2‐high phenotype in asthma
Background Hyperpolarized gas with helium (HHe‐3) MR (magnetic resonance) is a noninvasive imaging method which maps and quantifies regions of ventilation heterogeneity (VH) in the lung. VH is an important feature of asthma, but little is known as to how VH informs patient phenotypes. Purpose To det...
Gespeichert in:
Veröffentlicht in: | Pediatric pulmonology 2021-06, Vol.56 (6), p.1440-1448 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Hyperpolarized gas with helium (HHe‐3) MR (magnetic resonance) is a noninvasive imaging method which maps and quantifies regions of ventilation heterogeneity (VH) in the lung. VH is an important feature of asthma, but little is known as to how VH informs patient phenotypes.
Purpose
To determine if VH indicators quantified by HHe‐3 MR imaging (MRI) predict phenotypic characteristics and map to regions of inflammation in children with problematic wheeze or asthma.
Methods
Sixty children with poorly‐controlled wheeze or asthma underwent HHe‐3 MRI, including 22 with bronchoalveolar lavage (BAL). The HHe‐3 signal intensity defined four ventilation compartments. The non‐ventilated and hypoventilated compartments divided by the total lung volume defined a VH index (VHI %).
Results
Children with VHI % in the upper quartile had significantly greater airflow limitation, bronchodilator responsiveness, blood eosinophils, expired nitric oxide (FeNO), and BAL eosinophilic or neutrophilic granulocyte patterns compared to children with VHI % in the lower quartile. Lavage return from hypoventilated bronchial segments had greater eosinophil % than from ventilated segments.
Conclusion
In children with asthma, greater VHI % as measured by HHe‐3 MRI identifies a severe phenotype with higher type 2 inflammatory markers, and maps to regions of lung eosinophilia. Listed on ClinicalTrials. gov (NCT02577497). |
---|---|
ISSN: | 8755-6863 1099-0496 1099-0496 |
DOI: | 10.1002/ppul.25303 |